Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
89 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04557059 | A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer(PRIMORDIUM) | active not recruiting | Phase 3 | 691 | Janssen Pharmaceutica N.V., BelgiumINDUSTRY | 21 | Sep 25, 2026 | clinicaltrials |
| NCT05132075 | Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer(KontRASt-02) | active not recruiting | Phase 3 | 95 | Novartis Pharmaceuticals |
| 25 |
| Sep 25, 2026 |
| clinicaltrials |
| NCT04339478 | Does Parathyroid Autofluorescence Reduces Unintensional Parathyroidectomy During Total Thyroidectomy With Central Lymph Node Compartment Dissection(FLUOBCC) | completed | — | 180 | Aristotle University Of ThessalonikiOTHER | 2 | Sep 23, 2026 | clinicaltrials |
| NCT07065344 | A Multicenter Observational Study to Understand the Clinical Characteristics, Treatment Patterns and Access to Novel Therapies of Patients With Diffuse Large B-Cell Lymphoma in the MEA Region(DOMAIN) | recruiting | — | 500 | AstraZenecaINDUSTRY | 10 | Sep 23, 2026 | clinicaltrials |
| NCT05894239 | A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer(INAVO122) | recruiting | Phase 3 | 230 | Hoffmann-La RocheINDUSTRY | 29 | Sep 21, 2026 | clinicaltrials |
| NCT06687369 | A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study) | active not recruiting | Phase 3 | 726 | mAbxience Research S.L.INDUSTRY | 24 | Sep 10, 2026 | clinicaltrials |
| NCT07811856 | Effects of Metformin and Theory-Based Education in Women With Polycystic Ovary Syndrome | completed | Phase 4 | 900 | Jerash Private UniversityOTHER | 1 | Sep 10, 2026 | clinicaltrials |
| NCT07806266 | EORTC Metastatic Breast Cancer Module Development | recruiting | — | 568 | University of LeedsOTHER | 14 | Sep 8, 2026 | clinicaltrials |
| NCT07801235 | HYperfractionated Radiation Therapy Versus Concurrent Chemoradiation for Head and Neck Cancer (HYTC) | recruiting | N/A | 604 | King Hussein Cancer CenterOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT07803549 | The Effect of Self-Management Interventions Among Patients With Breast Cancer Related-Lymphedema((BCRL)) | completed | N/A | 100 | Al-Zaytoonah University of JordanOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT07793838 | Metformin Effects on Metabolic, Vitamin B12, Iron, Erythropoietin, and Hematological Parameters in Women With PCOS(MET-PCOS) | completed | Phase 4 | 400 | Jerash Private UniversityOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT05456191 | A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)(ASC4START) | active not recruiting | Phase 3 | 568 | Novartis PharmaceuticalsINDUSTRY | 24 | Aug 26, 2026 | clinicaltrials |
| NCT04603807 | A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases | active not recruiting | Phase 3 | 217 | Hoffmann-La RocheINDUSTRY | 18 | Aug 13, 2026 | clinicaltrials |
| NCT06468033 | P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk | active not recruiting | Phase 3 | 160 | PharmaEssentiaINDUSTRY | 9 | Aug 13, 2026 | clinicaltrials |
| NCT07759674 | Relationship Between Metformin Treatment, Anemia, and Erythropoietin Levels in Women With Polycystic Ovary Syndrome in Jordan(Metformin-APO) | completed | Phase 4 | 25 | Jerash Private UniversityOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT07371403 | MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia | recruiting | N/A | 12 | King Hussein Cancer CenterOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT06075758 | A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer | completed | — | 175 | Novartis PharmaceuticalsINDUSTRY | 3 | Jul 29, 2026 | clinicaltrials |
| NCT05653063 | ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate Cancer | active not recruiting | — | 1,029 | University College, LondonOTHER | 4 | Jul 22, 2026 | clinicaltrials |
| NCT05592938 | Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)(PRESERVE) | recruiting | N/A | 171 | University Health Network, TorontoOTHER | 10 | Jul 17, 2026 | clinicaltrials |
| NCT05296798 | A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) | active not recruiting | Phase 3 | 922 | Hoffmann-La RocheINDUSTRY | 29 | Jul 16, 2026 | clinicaltrials |
| NCT03591510 | A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML | active not recruiting | Phase 2 | 22 | Novartis PharmaceuticalsINDUSTRY | 10 | Jul 9, 2026 | clinicaltrials |
| NCT07690956 | Pharmacist-Led Education to Improve Neutropenic Precautions in Cancer Patients | active not recruiting | N/A | 300 | Jordan University of Science and TechnologyOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT03088540 | Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 712 | Regeneron PharmaceuticalsINDUSTRY | 24 | Jun 25, 2026 | clinicaltrials |
| NCT05491525 | Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC(KANGUROO) | recruiting | Phase 2 / Phase 3 | 71 | Urovant Sciences GmbHINDUSTRY | 16 | Jun 15, 2026 | clinicaltrials |
| NCT04937660 | Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC(PRECIOUS) | completed | — | 185 | PfizerINDUSTRY | 5 | Jun 10, 2026 | clinicaltrials |
| NCT05430971 | Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry | recruiting | — | 200 | Immune Oncology Research InstituteOTHER | 15 | Jun 5, 2026 | clinicaltrials |
| NCT05566795 | DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) | active not recruiting | Phase 3 | 418 | Day One Biopharmaceuticals, Inc.INDUSTRY | 30 | May 14, 2026 | clinicaltrials |
| NCT06528691 | Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors | recruiting | Phase 2 | 52 | St. Jude Children's Research HospitalOTHER | 4 | May 13, 2026 | clinicaltrials |
| NCT03515993 | Follow-up in Gynecological Cancer Survivors | active not recruiting | — | 1,100 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | May 12, 2026 | clinicaltrials |
| NCT03609047 | Adjuvant Palbociclib in Elderly Patients With Breast Cancer(Appalaches) | active not recruiting | Phase 2 | 366 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | May 12, 2026 | clinicaltrials |
| NCT03859453 | Follow-up in Early and Locally Advanced Breast Cancer Patients | completed | — | 830 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | May 12, 2026 | clinicaltrials |
| NCT07553260 | Effectiveness of 0.9% Normal Saline Soaking in Managing Acute Radiation Dermatitis | not yet recruiting | N/A | 150 | King Hussein Cancer CenterOTHER | 1 | Apr 27, 2026 | clinicaltrials |
| NCT04071704 | Assessing Health-related Quality of Life in Sarcoma Patients | completed | — | 654 | The Netherlands Cancer InstituteOTHER | 2 | Apr 22, 2026 | clinicaltrials |
| NCT07497451 | Enhancing Pain Management Among Patients Diagnosed With Stage III and Stage IV of Breast Cancer: The Power of Immersive and Non-Immersive Virtual Reality-Driven Interactive Guided Imagery | not yet recruiting | N/A | 90 | Middle East UniversityOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07478718 | Shoulder Exercise Training on Pain, Range of Motion, and Functional Limitations in Women Following Unilateral Mastectomy | not yet recruiting | N/A | 33 | South Valley UniversityOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT06470230 | RESPECT: (REsearching Stigma in PEdiatric Cancer Tool) | completed | — | 633 | St. Jude Children's Research HospitalOTHER | 3 | Mar 19, 2026 | clinicaltrials |
| NCT06054555 | A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma | active not recruiting | Phase 3 | 633 | AmgenINDUSTRY | 31 | Jan 12, 2026 | clinicaltrials |
| NCT07271121 | Study of CART Cell (MB-CART19.1) in Patients With Relapsed or Refractory CD19 Positive NHL | recruiting | Phase 2 | 26 | King Hussein Cancer CenterOTHER | 1 | Dec 9, 2025 | clinicaltrials |
| NCT03822468 | Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer(AMALEE) | completed | Phase 2 | 376 | Novartis PharmaceuticalsINDUSTRY | 23 | Oct 16, 2025 | clinicaltrials |
| NCT07175103 | RCT to Evaluate the Efficacy of the NSSCEP in Reducing Burnout Among Jordanian Pediatric Oncology Nurses(NSSCEP) | not yet recruiting | N/A | 80 | Universiti Putra MalaysiaOTHER | 1 | Sep 16, 2025 | clinicaltrials |
| NCT05014191 | Treatment Positioning in Vulvar Cancer Radiation Therapy | completed | — | 20 | King Hussein Cancer CenterOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT07112768 | LH/FSH, Testosterone, Prolactin, and Ferritin in PCOS Patients in Jordan(PCOS patients) | completed | — | 140 | Future University in EgyptOTHER | 1 | Aug 8, 2025 | clinicaltrials |
| NCT05190094 | Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.(ICRG0201) | recruiting | Phase 2 | 80 | International Cancer Research Group, United Arab EmiratesOTHER | 3 | May 7, 2025 | clinicaltrials |
| NCT04920513 | Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for Inherited Cancers in Non-Western Society. | completed | — | 3,000 | King Hussein Cancer CenterOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT04920656 | Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer | completed | — | 1,000 | King Hussein Cancer CenterOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT04203524 | Procalcitonin and Antimicrobial Utilization in Critically Ill Cancer Patients with Sepsis(Pro-Can) | terminated | N/A | 157 | King Hussein Cancer CenterOTHER | 1 | Mar 17, 2025 | clinicaltrials |
| NCT06779760 | Near Infrared Autofluorescence Imaging in Minimally-Invasive Video-Assisted Parathyroidectomy (NIRAF MIVAP Study)(NIRAF MIVAP) | completed | — | 24 | Aristotle University Of ThessalonikiOTHER | 1 | Jan 17, 2025 | clinicaltrials |
| NCT06292988 | Predictive Factors for Medullary Thyroid Cancer Aggressiveness(MYELO) | completed | — | 500 | Aristotle University Of ThessalonikiOTHER | 24 | Jan 3, 2025 | clinicaltrials |
| NCT04127110 | Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients(ALKALINE) | active not recruiting | Phase 2 | 68 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Nov 5, 2024 | clinicaltrials |
| NCT05428566 | A Comparison of a PULSE Diet and the TLC Diet on Reproductive, Metabolic Parameters in Women with PCOS | completed | N/A | 144 | University of JordanOTHER | 1 | Nov 1, 2024 | clinicaltrials |
Data updated 4 days agoSource updated unknownsource: clinicaltrials